Article

OBJECTIVE: To assess rehabilitation inpatient risk of return to primary (RTP)
service in patients with bone marrow transplant (BMT). DESIGN: Retrospective
review. SETTING: Inpatient rehabilitation unit within a tertiary referral-based
cancer center. PARTICIPANTS: All patients with BMT (131) who were admitted a
total of 147 times to inpatient rehabilitation between January 1, 2002, and April
30, 2010. INTERVENTIONS: None. MAIN : We analyzed RTP service and
demographic information, cancer characteristics, medications, hospital admission
characteristics, and laboratory values. RESULTS: A total of 61 (41%) of 147 of
BMT admissions were transferred from the inpatient rehabilitation unit back to
the primary service. Of those transferred back, 23 (38%) of 61 died after being
transferred back to the primary service. Significant or near-significant
relationships were found for a platelet count of <43,000 per microliter (P<.01);
a creatinine level of >0.9 milligrams/deciliter (P<.01); the presence of an
antiviral agent (P=.0501); the presence of an antibacterial agent (P=.0519); the
presence of an antifungal agent (P<.05); and leukemia, lymphoma, or multiple
myeloma diagnosis (P<.05). Using 5 of these factors, the RTP-BMT index was
formulated to determine the likelihood of return to the primary team.
CONCLUSIONS: Patients with BMT have a high rate of transfer from the inpatient
rehabilitation unit back to the primary service. The RTP-BMT index score can be a
useful tool to help clinicians predict the likelihood of return to the primary
acute care service.
CI - Copyright (c) 2013 American Congress of Rehabilitation Medicine. Published by
Elsevier Inc. All rights reserved.

Langue : ANGLAIS